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A B S T R A C T   
Background and aims: The impact of endothelial shear stress (ESS) on vessel remodeling in vessels implanted with 
bioresorbable scaffold (BRS) as compared to metallic drug-eluting stent (DES) remains elusive. The aim of this 
study was to determine whether the relationship between ESS and remodeling patterns differs in BRS from those 
seen in metallic DES at 3-year follow-up. 
Methods: In the ABSORB II randomized trial, lesions were investigated by serial coronary angiography and 
intravascular ultrasound (IVUS). Three-dimensional reconstructions of coronary arteries post-procedure and at 3 
years were performed. ESS was quantified using non-Newtonian steady flow simulation. IVUS cross-sections in 
device segment were matched using identical landmarks. 
Results: Paired ESS calculations post-procedure and at 3 years were feasible in 57 lesions in 56 patients. Post- 
procedure, median ESS at frame level was higher in BRS than in DES, with marginal statistical significance 
(0.97 ± 0.48 vs. 0.75 ± 0.39 Pa, p = 0.063). In the BRS arm, vessel area and lumen area showed larger increases 
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in the highest tercile of median ESS post-procedure as compared to the lowest tercile. In contrast, in DES, no 
significant relationship between median ESS post-procedure and remodeling was observed. In multivariate 
analysis, smaller vessel area, larger lumen area, higher plaque burden post-procedure, and higher median ESS 
post-procedure were independently associated with expansive remodeling in matched frames. Only in BRS, 
younger age was an additional significant predictor of expansive remodeling. 
Conclusions: In a subset of lesions with large plaque burden, shear stress could be associated with expansive 
remodeling and late lumen enlargement in BRS, while ESS had no impact on vessel dimension in metallic DES.   
1. Introduction 
Given the transient scaffolding and recovery of vasomotion in the 
instrumented vessels, bioresorbable scaffolds (BRS) have emerged as a 
potential solution for drawbacks of metallic drug-eluting stents (DES) 
that causes permanent vessel straightening and loss of compliance, dy-
namic vessel remodeling and mechanotransduction [1]. These short-
comings may influence vessel wall metabolism and contribute to late 
degeneration of intra-device neointima leading to neoatherosclerotic 
lesion formation. Despite unprecedented results from ABSORB II that 
made the Absorb BVS out of the market, the trials on BRS are ongoing 
non-stop [2]. 
During resorption of polymeric scaffold, late luminal enlargement 
with expansive remodeling has been documented [3], but biological 
and/or physiological determinants of this morphological and anatom-
ical processes are still elusive. 
Arterial remodeling, defined briefly as any change in vessel wall 
structure, is a complex process depending on several endogenous (pla-
que characteristics, oxidative stress, inflammation, calcification and 
collagen deposition) and environmental factors [4]. Homeostatic 
response of the vessel wall to hemodynamic and mechanical triggers is 
the main underlying process of arterial remodeling [5]. The relationship 
between lumen area, plaque-media area, and vessel area is at the 
foundation of the Glagov’s principle of compensatory expansive 
remodeling of the external elastic membrane (EEM) [5]. Regarding the 
modifications in these three compartments, there are miscellaneous 
scenarios of expansive or constrictive remodeling, increase or decrease 
in plaque/media and increase/decrease in lumen area [3,6]. Endothelial 
shear stress (ESS), the frictional force at the endothelial surface pro-
duced by flowing blood, is a preliminary cue for vessel remodeling. ESS 
is a dynamic entity related to macroscopic changes in blood flow [7,8]. 
The present study is the first to analyze and compare the impact of 
shear stress both in BRS and metallic stents. The researchers tried to see 
the long-term repercussions of biodegradable scaffold and metallic stent 
on the vessel wall and the change in shear stress within the treated vessel 
segments in both stent types. Detailed analyses of the remodeling have 
been previously reported by our group, as well as the potential inde-
pendent determinant of the remodeling [3]. The purposes of the present 
study were to determine whether ESS post-procedure is associated with 
vessel remodeling in instrumented arterial segments, and whether the 
relationship between ESS and remodeling patterns differs in BRS from 
those seen in metallic DES at 3-year follow-up. 
2. Patients and methods 
2.1. Study design and patient selection 
The ABSORB-II trial is a prospective, single-blind, multicenter trial 
that randomized 501 patients to percutaneous coronary intervention 
(PCI) with implantation of either Absorb BRS or Xience metallic DES in a 
2:1 fashion [9]. The protocol mandated documentary intravascular ul-
trasound (IVUS) pre-procedure and post-procedure and at 3-year 
follow-up. 
2.2. Data acquisition and analysis 
Two-dimensional (2D) quantitative coronary angiography (QCA) 
and IVUS data acquisition have been described previously [9]. For the 
present study, to correspond with the cardiac phase analyzed in QCA, 
the electrocardiogram (ECG)-gated end-diastolic cross-sectional frames 
in IVUS were used. 
All IVUS pullbacks were analyzed off-line by the independent core 
lab using the commercially available software (QIVUS version 2.2, 
Medis, Leiden, the Netherlands). The methods for quantitative analysis 
of IVUS have been reported previously [10]. As in the conventional 
analysis on IVUS, the device segments as well as the segments 5 mm 
proximal and distal to the device, were analyzed since beyond these 
regions, the effect of trauma by the device edge to trigger neointima 
growth is inexistent [11]. After scanning he population (n = 501 pa-
tients with 546 lesions), the 100 cases with 2 time points (n = 200 le-
sions) (post-implantation and 3-years), which fulfilled both criteria of 
(1) suitable coronary angiograms (minimal foreshortening and 
≥25◦angle difference between two angiograms) and (2) IVUS-VH (at 
least 5 mm edge segments proximal and distal to the treated segment 
both post-implantation and at 3-years follow-up) were included in the 
study. 
The increase or decrease in vessel area (or EEM area) defines the type 
of vascular remodeling, constrictive or expansive. In order to compare 
the BRS and metallic stent and due to the difficulty to measure the 
neointima in the biodegraded scaffold at 3-year, the intra-scaffold/stent 
neointima was incorporated in the metric of “plaque/media = vessel 
area–lumen area” [3]. In a previous study [12], performed on ex vivo 
human coronary arteries, relative range of inter-observer re-
producibilities of measurements for lumen, plaque-media, and vessel 
cross sectional areas based on two standard deviations of their mea-
surements were determined. Based on those relative ranges of 
inter-observer reproducibility measurements by Muramatsu et al. [12], 
Serruys et al. [3] defined relative changes in lumen area, 
plaque-media-area and vessel area as ±15%, ±22%, ±12%, respec-
tively. In compliance with these relative values of reproducibility by 
Muramatsu et al. [12] and relative changes of lumen, plaque-media and 
vessel area by Serruys et al. [3], there have been 9 theoretical patterns of 
vessel/lumen/plaque remodeling based on increase, no change, and 
decrease in each of these three parameters [3,6]. In the present study, 
vessel remodeling was defined as any positive or negative change in 
vessel area, assessed in a continuous fashion, without the use of binary 
cut-off criteria. 
2.3. Coronary artery reconstruction 
Three-dimensional (3D) model reconstruction of coronary artery was 
based on 3D-QCA of the vessel implanted with the device and co- 
registration of lumen contour of IVUS onto the centerline of the vessel 
reconstructed in 3D-QCA [13]. Following the recruitment of the cases 
that fulfilled the criteria of coronary angiogram and IVUS (n = 200 le-
sions), during the 3D vessel reconstruction for CFD work, 34 vessels 
could not be 3D reconstructed due to various technical points during the 
main vessel-side branch co-registration process. 
Three-dimensional QCA was performed using QAngioXA-3D 
(version-1.3 Medis, Leiden, the Netherlands).Two post-procedural end- 
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diastolic angiographic images with at least a 25◦-angle difference, and 
with minimal foreshortening were selected. In order to adjust for the 
effect of vessel curvature on the local hemodynamic forces [14], the 
proximal native vessel segment from its ostium was incorporated into 
the 3D-model (Fig. 1A). 
Side-branch (SB) proximal to the device segment (within a distance 
of 3 times the diameter of proximal-SB), SB in the device segment and SB 
distal to the device segment (within a distance of one-diameter of the 
distal-SB) were included to account for the effect of flow division and the 
effect of any flow disturbance caused by the carina zone of the SB. To 
achieve a realistic effect of flow division [15], side-branches ≥1.5 mm in 
QCA measurements were reconstructed and incorporated into the 
3D-model (Fig. 1B and C). 
Following 3D-QCA, lumen contours by IVUS within device segment 
and segments 5 mm proximal and distal to the device were co-registered 
onto the 3D-QCA centerline using 3D-Angio-IVUS Co-registration 
(Medis, Leiden, the Netherlands) (Fig. 1D) and a 3D-surface model 
was reconstructed using QAngio-CT 3D-Workbench (version-1.3.0.2, 
Medis, Leiden, the Netherlands) (Fig. 1E). 
2.4. Computational fluid dynamic study 
Following 3D-reconstruction of the coronary artery, the computa-
tional fluid dynamics (CFD) mesh was generated using ANSYS ICEM CFD 
17.0 (ANSYS,Inc. Canonsburg, Pennsylvania). A typical cell size of 0.1 
mm was used and three prism layers at the wall were constructed, 
resulting in a mesh size of ~2 × 106 cells. In order to incorporate its 
shear-thinning behavior, blood was modeled as a non-Newtonian fluid 
by applying Carreau model with the parameters taken from Seo et al. 
[16]. The blood density was set to 1060 kg/m3. The vessel wall was 
modeled as rigid and no-slip condition was imposed at the wall. For the 
inflow and outflow conditions in the main vessel and side-branches, flow 
rates were estimated based on the diameter of the main vessel and SB, 
following the relationship derived from in vivo observations (scaling 
approach) [15,17]. During the scaling approach, the inlet velocities (V) 
were determined using the flow rates (Q) calculated by the diameters of 
the related vessel segments [15,17] and cross-sectional area (A) with the 
formula of Q = V/A (Supplementary materials). Poiseuille velocity 
profile was prescribed at the inlet based on the scaled flow rate. Since 
the association of ESS with vessel remodeling is based on time-averaged 
data over 3 years, we focused on steady flow simulations [18]. A 
finite-volume solver was used to perform steady-state simulations using 
standard numerical techniques (ANSYS Fluent v17.0,ANSYS, Inc. Can-
onsburg, Pennsylvania) (Fig. 1F). 
In post-processing the CFD result, cross-sections of the CFD models 
were located perpendicularly onto the lumen centerline and matched to 
the IVUS frames using in-house algorithms to be able to export mean, 
median, minimum, and maximum ESS at frame level (a distance of 
adjacent frames: median 0.42 [interquartile range 0.38, 0.50] mm). 
During the co-localization and orientation between the cross-sections 
from 3D CFD model and IVUS frames, side-branches were utilized 
incorporating the horizontal angle degree of the SB with the centerline. 
During volume meshing, due to geometrical artefacts in bifurcation 
zones, 6 models could not be meshed, and due to low mesh quality 14 
models could not be simulated. Following the CFD simulation of 146 
lesions, 14 models could not be processed during the post-processing 
step. At the end, there were 57 patients both with post-implantation 
and 3 year shear stress simulation successfully post-processed. 
2.5. Matching frames among pre-procedure, post-procedure and 3-year 
follow-up 
IVUS cross-sections were matched for pre-procedure, post-procedure 
and 3-year follow-up using identical landmarks such as scaffold/stent 
edges, side-branches and calcium locations so that serial changes of the 
lumen, plaque, vessel area and ESS from post-procedure to 3-year could 
be analyzed at a cross-sectional level. Pre-procedural compositional 
information in IVUS-virtual histology (VH) was also matched with 
Fig. 1. Analysis steps for computational fluid dynamics (CFD) simulation in coronary artery. 
This figure shows the steps for CFD simulations in the study. Two orthogonal coronary projections displaying the treated vessel were processed in 3D-QCA software 
(A-C). 3D-QCA models were transferred to the dedicated software for co-registration to mount the IVUS-derived lumen and vessel contours on the 3D-centerline, 
which comes from 3D-QCA of the main vessel (D and E). Following the workbench step, luminal volume was meshed and the meshed model was then processed 
in a CFD software to simulate the flow in the reconstructed vessel model (F). The details for the analysis steps can be found in the Supplementary materials. (For 
interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) 
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frames at later time points. Matching was performed using dedicated 
software [QCU-CMS software version-4.69 (Leiden University Medical 
Center, Leiden, Netherlands)] [19]. 
2.6. Statistical analysis 
At patient or device level, categorical variables were compared using 
Pearson’s chi-square test or Fischer’s exact test, as appropriate. 
Continuous variables were compared using Student t-test. 
Analyses were carried out using variables per each cross-section 
(frame) in device segment. Frame-level ESS between devices or be-
tween post-procedure and at 3-year was compared using linear mixed 
model, taking into account the clustering nature of the data within de-
vice or patient. Terciles of median-ESS at a frame level were determined 
based on pooled cross-sectional data.The relationships between terciles 
of post-procedural median-ESS and cross-sectional changes of the 
lumen, plaque, vessel area, and plaque burden were analyzed by linear 
mixed-model adjusted for multiple comparisons by Bonferroni 
correction. 
Multivariate linear mixed-model predicting vessel area change was 
constructed using variables with p-value <0.10 in univariate analysis. 
Post-procedural median-ESS was forced to enter in the model as a pri-
mary variable of interest. A p-value<0.05 was considered statistically 
significant. Statistical analyses were performed with SPSS version- 
24.0.0.2 (IBM,Armonk, New York). 
3. Results 
3.1. Baseline patient characteristics, angiographic and IVUS results 
Out of 546 lesions in 501 patients enrolled in ABSORB-II trial, paired 
ESS post-procedure and at 3 years were analyzable in 35 lesions in 35 
patients in the BRS arm and 22 lesions in 21 patients in the DES arm. The 
study flowchart is shown in Fig. 2. 
Baseline (pre-procedure) clinical and lesion characteristics are 
tabulated in Table 1. Patient, lesion and procedural features were well 
balanced between two device groups. The pre-procedural IVUS 
parameters were also comparable between the study groups (Supple-
mentary Table 1). 
Post implantation and at 3 years, both mean and minimum luminal 
diameters by QCA were smaller in the BRS arm than in the DES arm 
(Supplementary Table 2). 
Mean and minimum lumen area post-implantation, as measured by 
IVUS, were smaller in the BRS arm, when compared to the metallic DES 
arm (Supplementary Table 3). Post-implantation mean vessel area was 
significantly smaller in BRS arm than in DES arm (12.78 ± 3.20 vs. 
14.97 ± 2.98, p = 0.012). However, at 3-year follow-up, mean vessel 
area was no longer statistically different, as a result of expansive 
remodeling in BRS arm and constrictive remodeling in DES arm in 
combination with some loss in lumen area (change in mean vessel 
area:+0.78 ± 1.49 vs. − 0.66 ± 1.64 mm2, p = 0.001). 
3.2. Endothelial shear stress: comparison between devices and serial 
evolution 
Table 2, Fig. 3 and Supplementary Figure 1 show changes in the 
lumen, plaque, vessel area (mm2) and plaque burden (%) over 3 years 
among the terciles of ESS post-procedure (~0.658; 0.658–0.953; 
0.953~Pa). In BRS arm, the lowest-tercile of ESS showed a decrease in 
lumen area as opposed to late lumen enlargement in the intermediate- 
and the highest-terciles. There is a significant difference in plaque-media 
area, increasing in BRS (+0.64 ± 1.10 mm2) and decreasing in Xience 
(− 0.46 ± 1.22 mm2). The vessel segments implanted with BRS 
demonstrated a higher ESS as compared to those with DES both post- 
procedure and at 3 years (Supplementary Figure 1). 
In BRS, increase in plaque area from post-procedure to 3-year follow 
up was not different among the three terciles of ESS post-procedure, and 
vessel area showed a larger increase in the highest-tercile as compared 
to the lowest-tercile of ESS post-procedure. Consequently, the lowest 
tercile of ESS post-procedure showed an increase in plaque burden 
(+5.36 ± 8.98%) significantly larger than intermediate (1.86 ± 8.09%) 
or highest (0.72 ± 7.46%) tercile of ESS post-procedure. In contrast, in 
DES arm, there was no significant difference in change in the lumen, 
plaque vessel areas and plaque burden amongst the 3 terciles of ESS 
Fig. 2. Study flow-chart. 
CFD = computational fluid dynamics, ESS = endothelial shear stress, IVUS = intravascular ultrasound. (For interpretation of the references to colour in this figure 
legend, the reader is referred to the Web version of this article.) 
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post-procedure (Fig. 3). 
The relationship between vessel area, lumen area and plaque burden 
at the frame level in case of expansive remodeling is presented in Fig. 4. 
While there was a linear relationship between vessel area change and 
lumen area change in Absorb, no such relationship was detected in 
metallic Xience. There was a negative relationship between the change 
in lumen area and plaque burden both in BRS and metallic stent. In 
Absorb, wall shear stress was inversely related to luminal area. How-
ever, there was no relationship between wall shear stress and luminal 
area in metallic DES. 
3.3. Predictors of vessel remodeling 
The results of univariate analysis predicting vessel area change 
(mm2) over 3 years in linear mixed-model are tabulated in Supple-
mentary Table 4. Following forced entry of variables with p < 0.10 in 
univariate analyses, as well as median-ESS post-procedure, a multivar-
iate model was constructed. Overall, smaller vessel area, larger lumen 
area, higher plaque burden post-procedure, and higher median ESS post- 
procedure were independently associated with expansive remodeling in 
matched frames (Table 3 and Fig. 5). Only in BRS, younger age was an 
additional significant predictor of expansive remodeling. 
Regarding any heterogeneity on the ESS and remodeling throughout 
the length of DES and BRS; in terms of ESS there were heterogeneity 
between the proximal, middle and distal vessel segments only in Absorb 
implanted vessel segments. In metallic Xience, such heterogeneity was 
not identified. In Absorb, changes in VA between post-implantation and 
3-year follow up had a significant relationship to ESS in the middle zones 
of the device implanted vessel segments. However, in metallic Xience, 
there was no such relationship between ESS and VA change in either 
distal, middle and proximal zones of Xience implanted vessel segments 
(Supplementary Table 5). 
4. Discussion 
Although the bioresorbable scaffold Absorb is no longer commer-
cially available, it is the BRS that has been the most widely used and 
studied, and long-term follow up of COMPARE, AIDA, ABSORB-III and 
-IV have still to be reported. The Absorb device is representative of a 
generic or class effect that will be encountered with other BRS. Any 
fundamental pathophysiological mechanisms investigated on this 
archetype of BRS, such as dismantling, remodeling, late lumen 
enlargement, will be probably replicated in novel scaffolds with thinner 
struts currently in trial. However, the Absorb remains the first historical 
device in which the effect of shear stress on scaffolded vessel segments 
has been investigated. 
The main findings of the present study were: (1) The vessel segments 
implanted with BRS demonstrated a higher ESS as compared to those 
with DES both post-procedure and at 3 years; (2) overall, higher median- 
ESS, smaller vessel area, larger lumen area, and higher plaque burden 
post-procedure were independently associated with expansive remod-
eling at long term follow-up; (3) only in BRS, younger age was an 
additional significant predictor of expansive remodeling. To the best of 
our knowledge, this is the first study investigating ESS in BRS and DES in 
the context of a randomized trial. 
4.1. The implication of “macro” shear stress assessed by IVUS 
In ABSORB-II, we tried to unravel the phenotype complexity of the 
remodeling of the lumen, plaque-media and vessel area. The lower 
resolution of IVUS (80–150 μm), as compared to optical coherence to-
mography (OCT) (10–20 μm), allowed us to explore ESS only in a 
“macro” hemodynamic environment rather than in a “micro” environ-
ment only analyzable by OCT [20]. OCT was not mandated in the 
ABSORB-II trial, however, in the pilot study (Absorb Cohort-B) prior to 
the randomized trial, the assessment of acute and chronic (5 years) shear 
stress between and on top of the struts had been carefully documented 
by OCT [21]. 
However, remodeling of vessel area and change in plaque burden 
cannot be captured by OCT that can only analyze endoluminal lining, 
whereas IVUS can measure plaque, media and vessel area (EEM area). 
Although bioresorption is not completed at 36 months, comparative 
analysis of the remodeling in Xience and Absorb at 36 months published 
by our group and clearly indicated that major constrictive or expansive 
remodeling already occurred at 3 years [3]. The current study tried to 
elucidate impact of the shear stress post implantation on caged and 
uncaged vessel wall. 
Table 1 
Baseline patient, lesion characteristics and procedure details.   
BRS DES p 
value 









Male 20 (57.1) 20 (95.2) 0.002 
Current smoking 9 (25.7) 5 (23.8) 1.000 
Hypertension requiring medication 27 (77.1) 15 (71.4) 0.752 
Dyslipidemia requiring medication 28 (80.0) 13 (61.9) 0.212 
Diabetes 8 (22.9) 1 (4.8) 0.132 
Unstable angina 4 (11.4) 3 (14.3) 1.000 
Prior MI 8 (22.9) 5 (23.8) 1.000 
Previous PCI 13 (37.1) 9 (42.9) 0.780 
Obesity (BMI ≥30 kg/m2) 8 (22.9) 7 (33.3) 0.534 
Lesion characteristics 35 lesions 22 lesions  
Lesion location 
Right coronary artery 10 (28.6) 7 (31.8) 0.415 
Left anterior descending 15 (42.9) 12 (54.5)  
Left circumflex artery 10 (28.6) 3 (13.6)  
Lesion classification 
A 1 (2.9) 0 (0.0) 0.628 
B1 13 (37.1) 10 (45.5)  
B2 21 (60.0) 12 (54.5)  
Procedural details 
Pre-dilatation performed 35 
(100.0) 
21 (95.5) 0.386 




































Post-dilatation performed 23 (65.7) 17 (77.3) 0.391 





















Expected diameter of post-dilatation/ 




















BMI = body mass index, BRS = bioresorbable scaffold, DES = drug-eluting stent, 
LDL = low-density lipoprotein, MI = myocardial infarction, PCI = percutaneous 
coronary intervention. 
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Table 2 
Changes in lumen, plaque, vessel area and plaque burden in matched frames stratified by median ESS.  









Lowest vs. intermediate 
tercile 
Lowest vs. Highest 
tercile 
Intermediate vs. highest 
tercile 
Median ESS Range (Pa) ~0.658 0.658–0.953 0.953~     
Number of frames 516 497 728     




0.18 ± 1.39 0.57 ± 1.28 0.003 <0.001 0.082  
Delta plaque area 
(mm2) 
0.92 ± 1.54 0.58 ± 1.79 0.76 ± 1.59 0.249 0.283 1.000  
Delta vessel area 
(mm2) 
0.66 ± 1.79 0.76 ± 2.19 1.34 ± 1.99 0.779 0.036 0.284  
Delta plaque burden 
(%) 
5.36 ± 8.98 1.86 ± 8.09 0.72 ± 7.46 0.011 <0.001 0.304 









Lowest vs. intermediate 
tercile 
Lowest vs. highest 
tercile 
Intermediate vs. highest 
tercile 
Median ESS Range (Pa) ~0.658 0.658–0.953 0.953~     
Number of frames 388 397 168     




− 0.16 ± 0.84 − 0.23 ±
0.73 
1.000 1.000 1.000  




− 0.30 ± 1.51 − 0.21 ±
1.85 
0.487 1.000 1.000  




− 0.46 ± 1.70 − 0.43 ±
1.79 
0.367 1.000 1.000  
Delta plaque burden 
(%) 
0.77 ± 7.73 0.12 ± 5.53 0.22 ± 6.74 1.000 1.000 1.000 
*p-values were by linear mixed model, corrected for multiple comparison. ESS = endothelial shear stress. 
Fig. 3. Changes in lumen, plaque, vessel area and plaque burden in matched frame stratified by terciles of median-ESS post-procedure. 
Stratification by terciles of median ESS post-procedure: ~0.658, 0.658–0.953, 0.953~Pa. Thresholds of terciles were derived from frame-level data with all lesions 
pooled. here were 1741 and 953 frames (2:1 randomization) with paired ESS values post-procedure and at 3 years in the BRS and DES arm, respectively. p-value 
<0.05 (by linear mixed model, corrected for multiple comparisons). ESS = endothelial shear stress. (For interpretation of the references to colour in this figure 
legend, the reader is referred to the Web version of this article.) 
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When compared to DES, smaller post-procedural lumen area in BRS 
(Supplementary Table 3) was expected to be the main determinant of 
post-procedural higher “macro” ESS by QCA-IVUS-derived 3D-coronary 
artery model. At 3-year follow-up, mean lumen area exhibited an in-
crease in BRS and a decrease in DES, which resulted in comparable mean 
lumen area with the two devices. 
In BRS, significant increase in vessel and lumen area at 3-years follow 
up was documented in vessels with the highest tercile of shear stress 
post-procedure. A significant difference in plaque-media area, 
increasing in BRS (+0.64 ± 1.10 mm2) and decreasing in Xience (− 0.46 
± 1.22 mm2), has to be underlined. This difference in behavior is highly 
significant (p < 0.001) and may be explained by the shrinking of the 
primary and short lasting inflammatory reaction due to the barotrauma 
in the metallic drug eluting sten t [3], while in BRS the secondary long 
lasting phase of inflammatory reaction is mainly due to the bio-
resorption of the polymer and generates an increase in plaque-media 
area (plaque burden) that contributes certainly to the increase in the 
vessel area [22]. 
In contrast, in the DES arm, there was no significant difference in 
change in the lumen, plaque vessel area and plaque burden amongst the 
3 terciles of ESS post-procedure. 
In BRS, increase in mean lumen area resulted in lowering of the 
Fig. 4. Correlations between change in 
vessel and lumen area, between relative 
change in lumen area and relative change in 
plaque burden, and between relative change 
in lumen area and change in median shear 
stress, in patients exhibiting expansive 
remodeling in Absorb and metallic Xience 
groups, respectively (analysis at frame 
level). 
VE = vessel area, LA = lumen area, PB =
plaque burden, WSS = wall shear stress. (For 
interpretation of the references to colour in 
this figure legend, the reader is referred to 
the Web version of this article.)   
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median ESS over 3 years, which is expected from the standard fluid 
dynamic laws, and illustrated in Fig. 5 [23]. 
4.2. Predictors of vessel remodeling 
4.2.1. Endothelial shear stress post-procedure 
Higher ESS was one of the independent predictors of expansive 
remodeling. This is in line with other previous studies in native vessels 
[24–26]. High ESS can stimulate the production of metalloproteinases 
by macrophages, which could contribute to expansive remodeling [27, 
28]. On the contrary, in lesions implanted with bare metal stent or DES, 
ESS did not impact on vessel remodeling in IBIS-4 [29]. It is of note that 
BRS had p-value<0.10 in univariate analysis; however, in the multi-
variate model, it was not retained while ESS was with a significant 
Table 3 
Multivariate model predicting vessel area change (mm2) over 3 years.   
Overall Absorb Xience 
coefficient 95% CI p value coefficient 95% CI p value coefficient 95% CI p value 
Age (per year) − 0.07 (-0.21,0.07) 0.329 − 0.22 (-0.39,-0.04) 0.016 0.09 (-0.10,0.28) 0.330 
Female 0.57 (-2.61,3.75) 0.715 0.54 (-2.10,3.19) 0.676 3.11 (-6.69,12.92) 0.510 
Absorb implantation 0.04 (-2.67,2.75) 0.975 NA 
IVUS post-procedure 
Vessel area (per mm2) − 0.74 (-0.92,-0.56) <0.001 − 0.70 (-0.92,-0.48) <0.001 − 0.92 (-1.27,-0.56) <0.001 
Lumen area (per mm2) 0.78 (0.43,1.13) <0.001 0.66 (0.19,1.12) 0.006 1.16 (0.59,1.73) <0.001 
Plaque area (per mm2) NAa 
Plaque burden (per %) 0.10 (0.06,0.15) <0.001 0.10 (0.05,0.15) <0.001 0.14 (0.05,0.24) 0.002 
Median ESS post-procedure (per Pa) 0.45 (0.01,0.89) 0.046 0.59 (0.16,1.01) 0.009 0.21 (-1.12,1.54) 0.740 
CI = confidence interval, ESS = endothelial shear stress, IVUS = intravascular ultrasound, NA = not available. 
a Not shown because it is redundant. 
Fig. 5. Post-procedural endothelial shear stress and changes in IVUS parameters during 3 years in a case of expansive remodeling in BRS. 
(Upper panels) 3D representation of endothelial shear stress (ESS) distribution post-procedure (left) and at 3 years (right) in a vessel implanted with bioresorbable 
scaffold (BRS). The scaffolded segment is located between white lines. The red line indicates matched sites whose cross-sectional images are shown in the lower 
panels. At this cross-section, median ESS post-procedure was 1.70Pa (highest tercile in the analysis population). Subsequently, vessel area increased by 3.24 mm2 
with lumen enlargement of 1.83 mm2. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) 
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p-value. This fact indicates that the device type would impose restriction 
on remodeling (i.e. metallic DES would restrict remodeling whereas BRS 
would not). The dismantling of the polymeric structure and the in-
flammatory reaction around the polymeric struts permit the shear stress 
to act on the vessel wall in BRS. The durable skeleton of the metallic 
stent could not provide such a flexible “environment” for shear stress, 
precluding its influence on the vessel wall. Instead of outward expansive 
remodeling with potentially late lumen enlargement, seen with the 
polymeric scaffold, in metallic stents relatively high ESS could only 
prevent an exuberant intrastent neointimal hyperplasia. Lower ESS had 
raising effect for vessel area however compared to the higher ESS it was 
significantly less. Nevertheless, lower ESS had decremental effect on the 
lumen area contrary to higher ESS. 
On the other hand, to explain the vessel long-term behaviors only 
with ESS value measured at a one-time point -post-implantation ESS or 
ESS at 3 years-may be problematic. Due to its nature, shear stress is not a 
static entity. It has a dynamic behavior which closely depends on the 
temporal and spatial changes within the flow area [30]; teleologically, 
the response to a decreased shear stress post-implantation of the scaffold 
will be a narrowing of the vessel lumen in order to restore the shear stress 
in its physiological range. Conversely, high post-implantation shear 
stress will regulate mechanotransduction processes that will result in an 
enlargement of lumen and vessel area of the scaffold,-as soon as its 
mechanical integrity has subsided-to eventually decrease the shear 
stress level back to physiological range (1–7Pa) [31]. 
4.2.2. Post-procedural vessel, lumen area and plaque burden 
Smaller post-procedural vessel area was independently associated 
with expansive remodeling. A similar relationship was already observed 
by Zarins et al. in pressure-perfusion-fixed postmortem adult human 
coronary arteries [32]. In other words, the smaller the vessel is, the more 
capable it is of expansive remodeling. In the Absorb group there is some 
relationship between change in vessel area and lumen area, between 
lumen area and plaque burden and relative change in lumen area and 
ESS(R2 = 0.310). In the Xience group, such relationship between lumen 
area and wall shear stress (R2 = 0.005) does not exist (Fig. 4). 
Larger lumen area post-procedure is another independent predictor 
of expansive remodeling. Larger lumen area could be either due to good 
scaffold/stent expansion or large vessel size. In our previous study, with 
a sample size of 501 patient, high balloon-artery ratio was a predictor of 
expansive remodeling [3], and could have resulted in larger lumen area. 
Glagov et al. reported that lumen area is preserved until plaque 
burden reaches 40–50% of the vessel area, as a result of a compensatory 
expansive remodeling [5]. However, beyond the value of 40–50%, the 
compensatory expansive remodeling gets exhausted with subsequent 
reduction in lumen area, at the pro rata of the increase in plaque burden. 
Post-procedural plaque burden in the present study population was on 
average 54.6 ± 6.0% (BRS) and 54.3 ± 5.5% (DES) in both arms. 
4.2.3. Age and capability of remodeling 
The coefficient of age (per year) in the multivariate model was 
negative with significant p-value only in the stratified analysis in BRS. In 
other words, younger patients are more prone to show expansive 
remodeling only in BRS. This could be explained by the fact that matrix 
metalloproteinase-9, an enzyme which enhances expansive remodeling, 
decreases as a function of age [33]. Apparently, the relationship of age 
and remodeling is weaker in the vessel segments caged by metallic DES. 
4.2.4. Tissue component 
In our previous report analyzing vessel remodeling at the device 
level, pre-procedural necrotic core was significantly associated with 
expansive remodeling [3]. However, in the present study, none of the 
tissue components documented by IVUS-VH was retained as a significant 
predictor of expansive vessel remodeling. A study with larger sample 
size may unravel interactions between tissue composition, vessel 
remodeling and ESS. 
4.3. Limitations 
The retrospective nature of this post-hoc study may be subject to a 
potential selection bias, and thus, the reported results should be regar-
ded as hypothesis-generating. There were also too few events to allow 
construction of a comprehensive multivariable model that would have 
explored the value of ESS in predicting clinical outcomes. Although ESS 
analyses were attempted on the entire randomized population of 
ABSORB II (n = 501 patients), due to eligibility criteria for each step in 
the study and technical difficulties, a large number of patients had to be 
excluded. Similarly, in the PROSPECT study, researchers could only 
include 14% of the original cohort in the ESS sub-study for comparable 
reasons [34]. 
During the matching of the IVUS frames pre-procedural, post-pro-
cedural and 3 years at follow up, the researchers used identical land-
marks such as scaffold/stent edges, side-branches and calcium locations 
so that serial changes of the lumen plaque, vessel area and ESS from 
post-procedure to 3 years could be analyzed at a cross-sectional level. 
Inter-observer variability was not assessed during the matching process 
and might potentially have inevitable impact on the results. 
Assumptions are inevitable in computational flow modeling. Our 
models include side branches and non-Newtonian blood behavior – both 
of which are often simplified more – and the only major assumption was 
the steady state flow condition. It has been shown that steady flow 
condition captures well the time-averaged shear stress [35] and is used 
as an effective predictor of disease progression [18]. Pulsatile flow 
condition would be required in case the oscillatory nature of flow and 
shear stress is of interest [36], which is warranted as our future study. 
CFD was applied to compute ESS in the stented segments, and several 
assumptions were made, potentially effecting the accuracy of the com-
putations. The most prominent assumption deals with applying scaling 
laws to estimate the flow rates in the main branch and the side branches. 
This assumption can influence average ESS values up to 8% [15]. It has 
to be noted though that the largest impact was seen near side branches, 
so we expect a smaller effect in the stented segments. 
In future studies investigating the effect of ESS and vessel remodel-
ing, a hybrid IVUS-OCT catheter may be preferred, as it could measure 
concomitantly lumen area, vessel area, plaque-media area and micro 
flow disturbance with precise co-registration, as recommended in the 
expert consensus on ESS [31]. 
4.4. What is already known? 
In bioresorbable scaffold (BRS) due to lower radial force, the lumen 
area post-implantation is smaller than the metallic stent. Due to smaller 
lumen area in BRS, endothelial shear stress (ESS) is relatively higher in 
BRS than in metallic stent. At follow up, with higher shear stress and the 
degradation of the polymeric scaffold, the vessel remodels and the vessel 
area start to expand. On the other hand, in metallic stents, there is no 
such opportunity of structural modification in the vessel wall due to the 
fixed metallic cage. Instead, the neointimal hyperplasia increases inside 
the metallic cage with a reduction in lumen area. Shear stress has impact 
on neointimal hyperplasia in the metallic caged vessel segments. 
4.5. What does this study add? 
Shear stress had significant influence on the expansive behavior of 
the BRS implanted vessels whereas no such effect was noted in metallic 
caged vessel segments. The present study is the first to reveal that high 
shear stress may have impact on expansion of the vessels instrumented 
with polymeric scaffolds. 
4.6. How might this impact on clinical practice? 
The development in the 3D vessel reconstruction and 3D CFD 
modeling may facilitate virtually the planning of stent/scaffold 
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implantation prior to PCI in the cath-lab. In the future, with ultra-high- 
speed computers, “online CFD simulation” may provide assessment of 
the optimized implantation of the polymeric scaffold. Virtual stenting 
enables planning and selection of an optimal treatment strategy. Post- 
implantation shear stress assessment may provide insights into the he-
modynamic micro-environment and this may shed light on the potential 
vascular behaviors at long-term follow up that can alert the clinicians for 
any potential adverse events. 
4.7. Conclusions 
Coronary segments implanted with BRS were exposed to higher ESS 
post-procedure as compared to DES. Post-procedural higher median ESS, 
smaller vessel area, and higher plaque burden were independent pre-
dictors of expansive remodeling and late lumen enlargement at 3 years. 
Only in the BRS, younger age was an additional significant predictor of 
expansive remodeling. 
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